Research
The role of PKC phosphorylation in modulating cardiac contractility
There are significant differences between a healthy heart
and one that is in end stage failure. There is, however, little known of the
molecular mechanisms that cause a sound muscular pump to become weak and
inefficient. One of the characteristics of a failing heart is a chronic
increase in the expression of the alpha- and beta- isoforms of protein kinase C (PKC). This altered cell signaling pathway is thought to
be at least partially responsible for the enhanced lusitrophy, and compensatory
hypertrophy that are hallmarks of the maladaptive changes that lead to heart
failure. Two targets for
phosphorylation by PKC in the cardiac myocyte are the thin filament proteins,
troponin I (TnI) and troponin T (TnT). These, along with troponin C (TnC),
comprise the troponin complex (Tn). TnI and TnT are involved in transmitting
the Ca2+ activation signal from TnC to the rest of the contractile
element. This signal transmission is thought to be modulated by PKC
phosphorylation and results in a decrease in Ca2+ sensitivity and
MgATPase activity. A chronic expression of PKC has been suggested to impair the
ability of the myocardium to modulate Ca2+ activation. There are two goals of this research project. The first is to characterize how the
phosphorylation of TnI and TnT by PKC alters the Ca2+ activation of
isolated Tn, and then determine how this translates into changes in MgATPase
activity and the kinetics of Ca2+ activated force generation. The
second goal is to determine the sensitivity of the contractile element to
increasing levels of Tn phosphorylation by PKC. These experiments are utilizing
steady-state Ca2+ binding measurements and stopped flow kinetic
analysis to measure the Ca2+ affinity of Tn in solution and the rate
of Ca2+ disassociation (koff), respectively. In addition,
we are characterizing the influence of PKC phosphorylation on the kinetics of Ca2+
activation using skinned cardiac trabeculae.
Functional
characterization of trout cardiac troponin I and cardiac troponin
T:
The Ca2+ sensitivity of force generation by trout
cardiac tissue is ~10 fold that of mammalian cardiac tissue. It is thought that this high Ca2+
sensitivity is responsible for enabling cardiac function in trout at their
comparatively low physiological temperature. We have previously demonstrated
that the Ca2+ affinity of trout cardiac troponin C (ScTnC) is 2.3
fold that of human cTnC. cTnC is the Ca2+
activated trigger that initiates myocyte contraction. We also identified the residues responsible
for the high Ca2+ affinity of ScTnC. By replacing native cTnC in
rabbit cardiac myocytes with a McTnC containing these identified residues we
were able to incease the Ca2+ sensitivity of force generation by 2
fold. This clearly demonstrates that ScTnC is partly responsible for the
comparatively high Ca2+ sensitivity of trout cardiac myocytes. As the Ca2+ sensitivity of trout
cardiac tissue is 10 fold that of mammalian cardiac tissue it is thought that
it is functional differences of trout cardiac troponin I (cTnI) and trout
cardiac troponin T (cTnT) that is responsible for the remaining difference in
Ca2+ sensitivity. To test
this hypothesis Kelly Kirkpatrick is currently cloning the genes for these
proteins. Once cloned and sequenced these genes will be expressed using E. coli and purified using column
chromatography. These proteins will then
be complexed with ScTnC. The function of
this troponin complex (ScTn) will then be characterized using Ca2+
binding studies and stopped flow kinetic analysis. ScTn will then be exchanged into mammalian cardiac
tissue and its influence on the Ca2+ activation of force generation
characterized.
Influence of cold
acclimation on contractile protein expression in the trout
heart:
We are interested in the abilities of the vertebrate heart
to respond to a stressor and we are using the trout heart as a model for these
studies. Trout remain active at low temperatures and cold acclimation causes
cardiac hypertrophy in these fish. This
hypertrophy is due to an increase in cell size, not cell number. It is thought the
hypertrophy is in response to an increase in blood viscosity that requires the
heart to work harder. We are interested
in how the structure and function of trout cardiac myocytes change during this
compensatory response. To characterize how cold acclimation influences the proteins
expressed within the heart, Jordan Klaiman is using 2D DIGE to analyze the
protein composition of cardiac myofilaments from fish that have been acclimated
to 4 C, 12 C and 17 C. Through this work we will be able to identify
any changes in protein isoform expression as well as changes in the phosphorylation
state of individual proteins. Through
integrating these results with measurements of actin myosin ATPase activity we
will be able to correlate changes in cross-bridge cycling rates with changes in
the proteome of the myofilaments.
Through this work we will identify specific mechanisms utilized to alter
the physiological capabilities of the heart.
Influence of hypoxia
on aerobic metabolism and cardiac development in trout embryos:
Hypoxia represents a stress routinely experienced by developing
trout embryos in their natural environment. We are interested in how hypoxia exposure
impacts aerobic metabolism and cardiac development/function in embryos. This
project is being done in collaboration with Dr. Pat Wright in Integrative
Biology. Silvana Miller has recently
completed a study where she characterized changes in metabolic rate and oxygen
levels within the developing embryo during chronic and acute hypoxia. She has demonstrated that the oxygen
consumption of chronically exposed embryos is less than that of acutely exposed
embryos in the latter stages of development.
This difference in oxygen consumption is due to the smaller size of the
chronically exposed embryos as a result of an impaired growth rate. We are also characterizing the influence of
chronic hypoxia on heart rate and cardiac gene expression. Heart rate is monitored through a microscope and gene expression is monitored using Q-PCR. The specific genes
we are monitoring are used as markers for cardiac growth and metabolism. Through this study we are working to
characterize the adaptive ability of the vertebrate heart during early
development.